I. Macgregor

发表

α‐Hemoglobin stabilizing protein is not a suitable marker for a screening test for variant Creutzfeldt‐Jakob disease

C. Prowse, N. E. Appleford, K. Wilson, 2008, Transfusion.

Plasma elastase levels and the development of the adult respiratory distress syndrome.

D. Steedman, K. Little, C. Haslett, 1995, American journal of respiratory and critical care medicine.

Inhibition of human factor Xa by various plasma protease inhibitors.

M. Scully, V. Kakkar, V. Ellis, 1982, Biochimica et biophysica acta.

Immunoassay of human plasma cellular prion protein

I. Macgregor, O. Drummond, 2001, Transfusion.

Cross-linked fibrin degradation products, progression of peripheral arterial disease, and risk of coronary heart disease

A. Rumley, F. Fowkes, I. Macgregor, 1993, The Lancet.

Molecular weight dependence of the anticoagulant properties of heparin: intravenous and subcutaneous administration of fractionated heparins to man.

V. Kakkar, I. Macgregor, D. Lane, 1979, Thrombosis research.

Plasminogen activator inhibitor (PAI‐1) in plasma and platelets

B. Bennett, I. Macgregor, N. Booth, 1988, British journal of haematology.

Effects of human PrPSc type and PRNP genotype in an in-vitro conversion assay

C. Prowse, M. Turner, J. Ironside, 2008, Neuroreport.

The effects of leukodepletion on the generation and removal of microvesicles and prion protein in blood components

C. Prowse, M. Turner, I. Macgregor, 2006, Transfusion.

Inhibition of human factor Xa by various plasma protease inhibitors.

M. Scully, V. Kakkar, V. Ellis, 1982, Biochimica et biophysica acta.

Evidence for a plasma inhibitor of the heparin accelerated inhibition of factor Xa by antithrombin III.

V. Kakkar, I. Macgregor, D. Lane, 1979, Biochimica et biophysica acta.

Modulation of human endothelial thrombomodulin by neutrophils and their release products.

C. Haslett, S. Donnelly, I. Macgregor, 1997, American journal of respiratory and critical care medicine.

Characterization of a monoclonal antibody to erythroid related factor.

K. Wilson, A. Morrison, I. Macgregor, 2011, Hybridoma.

Heparin receptors on mouse macrophages.

I. Macgregor, I. Bleiberg, M. Aronson, 1983, Thrombosis research.

Venous Occlusion Does Not Release von Willebrand Factor, Factor VIII or PAI-1 from Endothelial Cells – The Importance of Consensus on the Use of Correction Factors for Haemoconcentration

I. Macgregor, C. Ludlam, I. Wieczorek, 1993, Thrombosis and Haemostasis.

Reduction of the proteolytic activity of neutrophils by exposure to cigarette smoke in vitro.

W. MacNee, K. Donaldson, E. Drost, 1991, Experimental lung research.

Metabolism of Sodium Pentosan Polysulphate in Man – Catabolism of Iodinated Derivatives

C. Prowse, I. Macgregor, M. Smith, 1984, Thrombosis and Haemostasis.

Endothelial cells express normal cellular prion protein

I. Macgregor, I. Mackie, S. Machin, 2003, British journal of haematology.

The expression of prion protein by endothelial cells: a source of the plasma form of prion protein?

I. Macgregor, I. Mackie, S. Machin, 2002, British journal of haematology.

Human platelets as a substrate source for the in vitro amplification of the abnormal prion protein (PrPSc) associated with variant Creutzfeldt‐Jakob disease

C. Prowse, M. Turner, J. Ironside, 2008, Transfusion.

Application of an immunocapillary electrophoresis assay to the detection of abnormal prion protein in brain, spleen and blood specimens from patients with variant Creutzfeldt-Jakob disease.

J. Ironside, R. Will, I. Macgregor, 2006, The Journal of general virology.

An Antibody to the Aggregated Synthetic Prion Protein Peptide (PrP106–126) Selectively Recognizes Disease‐Associated Prion Protein (PrPSc) from Human Brain Specimens

J. Ironside, I. Macgregor, D. Wight, 2009, Brain pathology.

Production and characterization of a panel of monoclonal antibodies against native human cellular prion protein.

I. Macgregor, M. Head, C. Farquhar, 2009, Hybridoma.

Measurement of CD83 mRNA by real‐time polymerase chain reaction to determine removal of dendritic cells by leucoreduction of whole blood

A. Morrison, I. Macgregor, 2007, Transfusion medicine.

Prion protein in patients with renal failure

I. Macgregor, I. Mackie, S. Machin, 2006, Transfusion medicine.

The release of prion protein from platelets during storage of apheresis platelets

C. Prowse, I. Macgregor, O. Drummond, 2001, Transfusion.

The long-term effects of metoprolol and epanolol on tissue-type plasminogen activator and plasminogen activator inhibitor 1 in patients with ischaemic heart disease

K. Alberti, R. Riemersma, N. Boon, 2004, European Journal of Clinical Pharmacology.

Low proteins C and S and activation of fibrinolysis in treated essential thrombocythemia

I. Macgregor, C. Ludlam, I. Wieczorek, 1995, American journal of hematology/oncology.

Murine monoclonal antibodies against active site epitopes on human endothelial plasminogen activator inhibitor (PAI-1)

I. Macgregor, K. James, N. Booth, 1990 .

Plasminogen activator inhibitor from human endothelial cells. Purification and partial characterization.

B. Bennett, I. Macgregor, N. Booth, 1987, European journal of biochemistry.

A monoclonal antibody which prevents reductions in assayed fibrinogen and alpha 2 antiplasmin in plasma samples containing therapeutic concentrations of tissue plasminogen activator (t-PA).

C. Prowse, I. Macgregor, K. James, 1986, Thrombosis research.

The anti-heparin properties of human low-density lipoprotein.

V. Kakkar, I. Macgregor, D. Lane, 1980, Biochimica et Biophysica Acta.

Anticoagulant activities of four unfractionated and fractionated heparins.

V. Kakkar, I. Macgregor, D. Lane, 1978, Thrombosis research.

Urokinase and tissue-type plasminogen activators are present in breast cyst fluids.

W. Miller, I. Macgregor, 1988, European journal of cancer & clinical oncology.

Hypotensive effects of stroma‐free haemoglobin solutions attributable to adenine nucleotides

I. Macgregor, D. Pepper, S. Macdonald, 1991, Transfusion medicine.

The heparin-accelerated neutralisation of bovine α and β thrombins by antithrombin III

V. Kakkar, I. Macgregor, D. Lane, 1980 .

A Comparative Study Using Immunological and Biological Assays of the Haemostatic Responses to DDAVP Infusion Venous Occlusion and Exercise in Normal Men

C. Prowse, I. Macgregor, M. Mclaren, 1984, Thrombosis and Haemostasis.

Pulmonary endothelial permeability and circulating neutrophil-endothelial markers in patients undergoing esophagogastrectomy

C. Haslett, S. Donnelly, I. Macgregor, 2000, Critical care medicine.

Seminal Plasma Plasminogen Activator and Fertility

R. Elton, I. Macgregor, R. Elton, 2009, Andrologia.

CONCOMITANT MYELODYSPLASTIC SYNDROME AND CHRONIC MYELOID LEUKAEMIA: TREATMENT OUTCOMES WITH IMATINIB MESYLATE

I. Macgregor, I. Mackie, S. Machin, 2003 .

Fibrinolytic and Haemostatic Responses to Desamino-D-Arginine Vasopressin (DDAVP) Administered by Intravenous and Subcutaneous Routes in Healthy Subjects

C. Prowse, I. Macgregor, E. Roberts, 1988, Thrombosis and Haemostasis.

Tissue plasminogen activator in human plasma measured by radioimmunoassay.

C. Prowse, I. Macgregor, 1983, Thrombosis research.

Neutrophil elastase: a determinant of endothelial damage and reperfusion injury after liver transplantation?

P. Hayes, R. Jalan, A. Lee, 1996, Transplantation.

A Novel Rat Model of Thrombogenicity: Its Use in Evaluation of Prothrombin Complex Concentrates and High Purity Factor IX Concentrates

I. Macgregor, L. McLaughlin, O. Drummond, 1992, Thrombosis and Haemostasis.

Comparison of High Purity Factor IX Concentrates and a Prothrombin Complex Concentrate in a Canine Model of Thrombogenicity

C. Prowse, I. Macgregor, T. Burnouf, 1991, Thrombosis and Haemostasis.

Neutralization of heparin by Trasylol.

I. Macgregor, D. Lane, F. E. Preston, 1994, Annals of Thoracic Surgery.

Characterisation of Epitopes on Human Tissue Plasminogen Activator Recognised by a Group of Monoclonal Antibodies

I. Macgregor, K. James, D. Pepper, 1985, Thrombosis and Haemostasis.

Neoantigens and antibodies to factor VIII.

C. Prowse, I. Macgregor, 1998, Blood reviews.

Advances in the development of a screening test for variant Creutzfeldt-Jakob disease.

M. Turner, J. Ironside, I. Macgregor, 2008, Expert opinion on medical diagnostics.

Freezing of buffy coat–derived, leukoreduced platelet concentrates in 6 percent dimethyl sulfoxide

C. Prowse, A. Morrison, I. Macgregor, 2008, Transfusion.

Tandem purification of mouse IgM monoclonal antibodies produced in vitro using anion-exchange and gel fast protein liquid chromatography.

P. Clézardin, I. Macgregor, D. Pepper, 1986, Journal of chromatography.

Pathogen reduction of fresh plasma using riboflavin and ultraviolet light: effects on plasma coagulation proteins

C. Prowse, A. Morrison, I. Macgregor, 2009, Transfusion.

Extended storage of platelets in SSP+ platelet additive solution

C. Prowse, A. Morrison, I. Macgregor, 2006, Vox sanguinis.

Metabolism of Sodium Pentosan Polysulphate in Man Measured by a New Competitive Binding Assay for Sulphated Polysaccharides – Comparison with Effects Upon Anticoagulant Activity, Lipolysis and Platelet α-Granule Proteins

C. Prowse, I. Macgregor, J. Stocks, 1985, Thrombosis and Haemostasis.

A monoclonal antibody enzyme linked immunosorbent assay (ELISA) directed towards a fibrin binding region of tissue-type plasminogen activator

I. Macgregor, K. James, S. Macdonald, 1987 .

Age Dependent Changes in the Fibrinolytic System Are Well Established in Healthy Middle Aged Subjects

I. Macgregor, C. Ludlam, I. Wieczorek, 1992 .

The use of human endothelial cells cultured in flat wells and on microcarrier beads to assess tissue plasminogen activator and factor VIII related antigen release.

C. Prowse, I. Macgregor, D. Pepper, 1986, Thrombosis research.

ANTITHROMBIN III AND HEPARIN

P. G. Bentley, M. Scully, V. Kakkar, 1980, The Lancet.

Automated Control of Coumarin Therapy by Chromogenic Factor X Assay

M. Scully, I. Macgregor, R. Mibashan, 1979, Thrombosis and Haemostasis.

An objective study of alternative methods of heparin administration.

P. G. Bentley, M. Scully, V. Kakkar, 1980, Thrombosis Research.

Plasminogen activator inhibitor from human endothelial cells

B. Bennett, I. Macgregor, N. Booth, 1987 .

An Enzyme-Linked Immunosorbent Assay (ELISA) Used to Study the Cellular Secretion of Endothelial Plasminogen Activator Inhibitor (PAI-1)

I. Macgregor, N. Booth, N. A. Booth, 1988, Thrombosis and Haemostasis.

Quantitation by Radioimmunoassay of Thrombospondin Synthesised and Secreted by Human Endothelial Cells

I. Macgregor, D. Pepper, J. Dawes, 1984, Thrombosis and Haemostasis.

Prion protein and developments in its detection

I. Macgregor, Ian MacGregor, 2001, Transfusion medicine.

Purification of normal cellular prion protein from human platelets and the formation of a high molecular weight prion protein complex following platelet activation.

I. Macgregor, M. Head, D. Pepper, 2005, Biochemical and biophysical research communications.

Measurement of soluble fibrin in a variety of animal species.

I. Macgregor, L. McLaughlin, 1989, Thrombosis research.

Definition of Epitopes Within Plasminogen Activator Inhibitor Type-1 (PAI-1) Using Multiple Peptide Synthesis

I. Macgregor, N. Booth, A. M. Perrie, 1993 .

High Purity Factor IX and Prothrombin Complex Concentrate (PCC): Pharmacokinetics and Evidence that Factor IXa Is the Thrombogenic Trigger in PCC

G. Lowe, A. Rumley, I. Macgregor, 1996, Thrombosis and Haemostasis.

Application of a Time‐Resolved Fluoroimmunoassay for the Analysis of Normal Prion Protein in Human Blood and Its Components

C. Prowse, M. Turner, J. Hope, 1999, Vox sanguinis.

Application of a Time–Resolved Fluoroimmunoassay for the Analysis of Normal Prion Protein in Human Blood and Its Components

C. Prowse, M. Turner, J. Hope, 1999, Vox Sanguinis.

All Clinically-Relevant Blood Components Transmit Prion Disease following a Single Blood Transfusion: A Sheep Model of vCJD

C. de Wolf, C. Prowse, N. Hunter, 2011, PloS one.

Variation in concentration of prion protein in the peripheral blood of patients with variant and sporadic Creutzfeldt‐Jakob disease detected by dissociation enhanced lanthanide fluoroimmunoassay and flow cytometry

M. Turner, J. Ironside, G. Barclay, 2005, Transfusion.

Coagulation and fibrinolytic systems in type I diabetes: effects of venous occlusion and insulin-induced hypoglycaemia.

B. Frier, I. Macgregor, C. Ludlam, 1993, Clinical science.

The fibrinolytic system and proteins C and S in treated polycythaemia rubra vera.

R. Prescott, I. Macgregor, C. Ludlam, 1992, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Cross-reactivity of human molecular markers for detection of prethrombotic states in various animal species.

I. Macgregor, O. Drummond, I. McLaughlin, 1995, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

In vitro amplification and detection of variant Creutzfeldt–Jakob disease PrPSc

C. Prowse, J. Ironside, J. Manson, 2007, The Journal of pathology.

Study of endothelial t-PA and vWf in normal subjects and in von Willebrand's disease.

I. Macgregor, C. Ludlam, I. Wieczorek, 1994, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Release of highly-sulphated glycosaminoglycans and histamine from human basophils.

P. Yap, I. Macgregor, J. Dawes, 1988, International archives of allergy and applied immunology.

Studies on the removal of a bovine spongiform encephalopathy‐derived agent by processes used in the manufacture of human immunoglobulin

R. Somerville, I. Macgregor, K. Fernie, 2002, Vox sanguinis.